Beutels P - Search Results

1

Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.

Herzog SA, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, Coppens A, De Spiegeleer S, Beutels P, Van Damme P, Hens N, Theeten H. Herzog SA, et al. Among authors: beutels p. Euro Surveill. 2022 Mar;27(9):2100419. doi: 10.2807/1560-7917.ES.2022.27.9.2100419. Euro Surveill. 2022. PMID: 35241216 Free PMC article.

2

The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium).

Beutels P, Van Damme P, Van Casteren V, Gay NJ, De Schrijver K, Meheus A. Beutels P, et al. Vaccine. 2002 Oct 4;20(29-30):3551-9. doi: 10.1016/s0264-410x(02)00335-3. Vaccine. 2002. PMID: 12297401

3

The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).

Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, Damme PV. Thiry N, et al. Among authors: beutels p. Eur J Pediatr. 2002 Nov;161(11):588-93. doi: 10.1007/s00431-002-1053-2. Epub 2002 Sep 24. Eur J Pediatr. 2002. PMID: 12424583

4

Economic evaluations of varicella vaccination programmes: a review of the literature.

Thiry N, Beutels P, Van Damme P, Van Doorslaer E. Thiry N, et al. Among authors: beutels p. Pharmacoeconomics. 2003;21(1):13-38. doi: 10.2165/00019053-200321010-00002. Pharmacoeconomics. 2003. PMID: 12484801 Review.

5

Methodological issues and new developments in the economic evaluation of vaccines.

Beutels P, Van Doorslaer E, Van Damme P, Hall J. Beutels P, et al. Expert Rev Vaccines. 2003 Oct;2(5):649-60. doi: 10.1586/14760584.2.5.649. Expert Rev Vaccines. 2003. PMID: 14711326 Review.

6

An economic evaluation of varicella vaccination in Italian adolescents.

Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, Gabutti G, Van Damme P. Thiry N, et al. Among authors: beutels p. Vaccine. 2004 Sep 9;22(27-28):3546-62. doi: 10.1016/j.vaccine.2004.03.043. Vaccine. 2004. PMID: 15315834

7

Modelling age-dependent force of infection from prevalence data using fractional polynomials.

Shkedy Z, Aerts M, Molenberghs G, Beutels P, Van Damme P. Shkedy Z, et al. Among authors: beutels p. Stat Med. 2006 May 15;25(9):1577-91. doi: 10.1002/sim.2291. Stat Med. 2006. PMID: 16252265

8

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

Beutels P, Thiry N, Van Damme P. Beutels P, et al. Vaccine. 2007 Feb 9;25(8):1355-67. doi: 10.1016/j.vaccine.2006.10.034. Epub 2006 Nov 3. Vaccine. 2007. PMID: 17208339 Review.

9

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

Oosterhuis-Kafeja F, Beutels P, Van Damme P. Oosterhuis-Kafeja F, et al. Among authors: beutels p. Vaccine. 2007 Mar 8;25(12):2194-212. doi: 10.1016/j.vaccine.2006.11.032. Epub 2006 Dec 4. Vaccine. 2007. PMID: 17267077 Review.

10

Effectiveness of seven-valent pneumococcal conjugate vaccine.

Beutels P, Van Damme P. Beutels P, et al. Lancet. 2007 Feb 10;369(9560):460; author reply 460. doi: 10.1016/S0140-6736(07)60223-2. Lancet. 2007. PMID: 17292755 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters